Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS??? DEFICIT (Details Narrative)

v3.22.0.1
STOCKHOLDERS’ DEFICIT (Details Narrative)
 3 Months Ended 6 Months Ended 12 Months Ended
Nov. 30, 2021
USD ($)
$ / shares
shares
Sep. 30, 2021
USD ($)
$ / shares
shares
Aug. 12, 2021
USD ($)
$ / shares
shares
Jul. 20, 2021
USD ($)
Nov. 17, 2020
Dec. 31, 2021
USD ($)
$ / shares
shares
Sep. 27, 2021
USD ($)
shares
Dec. 31, 2020
USD ($)
Dec. 31, 2021
USD ($)
$ / shares
shares
Dec. 31, 2020
USD ($)
Jun. 30, 2021
USD ($)
$ / shares
shares
Dec. 31, 2021
AUD ($)
shares
Oct. 31, 2021
USD ($)
shares
Aug. 12, 2021
AUD ($)
Jun. 30, 2021
AUD ($)
shares
Feb. 04, 2020
shares
Feb. 03, 2020
shares
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Common stock shares authorized | shares           1,000,000,000     1,000,000,000   1,000,000,000 1,000,000,000     1,000,000,000 1,000,000,000 100,000,000
Stockholders equity reverse stock split         one-for-one thousand (1:1,000)                        
Preferred stock shares authorized | shares           1,500,005     1,500,005   1,500,005 1,500,005     1,500,005    
Preferred stock per share value | $ / shares           $ 0.01     $ 0.01   $ 0.01            
Stock issued during period, shares | shares                 8,799,956                
Common stock value           $ 53,062     $ 53,062   $ 14,056            
Common stock, par value | $ / shares           $ 0.001     $ 0.001   $ 0.001            
Interest payable current and non current           $ 52,548     $ 52,548   $ 34,098            
Share based compensation           $ 20,718   $ 20,718 $ 41,436 $ 41,436              
Share price | $ / shares           $ 0.044     $ 0.044                
Salary           $ 19,632     $ 19,632   $ 101,250 $ 27,000     $ 135,000    
Common stock shares issued | shares           53,062,209     53,062,209   14,055,393 53,062,209     14,055,393    
Deemed dividend                 $ 208,242                
Stock option expense                 $ 86,983                
Term of warrant           4 months 13 days     4 months 13 days     4 months 13 days          
Fourty Four Series A Warrants [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares           $ 200     $ 200                
Alternate cashless exercise price | $ / shares           0.001     0.001                
Alternate exercise price, at holder option | $ / shares           $ 200     $ 200                
Percentage of exercise of warrants and market price                 70.00%                
Chief Scientific Officer and Director [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Common stock value     $ 107,388                            
Stock issued during period shares employee benefit plan | shares     3,420,000                            
Shares issued price per share | $ / shares     $ 0.03                            
Share based compensation                 $ 4,788                
Adjustments to additional paid in capital stock issued issuance costs                 102,600                
Consultant Services [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Share based compensation                 104,611                
Accrued liabilities           $ 45,030     $ 45,030                
Convertible Debt [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Stock issued during period, shares | shares                 11,263,106                
Debt instrument contractual conversion price | $ / shares           $ 0.02     $ 0.02                
Debt instrument face amount           $ 214,848     $ 214,848                
Interest payable current and non current           9,813     9,813                
Conversion fees           2,250     2,250                
Proceeds from issuance of common stock                 226,912                
Premiums to additional paid in capital                 126,310                
Nathanielsz Cancellation Agreement [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Percentage of bonus of annual base salary     200.00%                            
Cancellation Agreement [Member] | Deferred Salary [Member] | Chief Scientific Officer and Director [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Salary     $ 102,600                            
Director Agreement [Member] | Josef Zelinger [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Stock issued during period, shares | shares                     2,800,000            
Common stock value                     $ 87,920            
Share based compensation                 3,920                
Share price | $ / shares                     $ 0.03            
Adjustments to additional paid in capital stock issued issuance costs                 84,000                
Salary     184                     $ 250.00      
Accrued liabilities                     $ 84,000            
Dutchess [Member] | Common Stock Purchase Agreement [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Agreement term 36 months                                
Lowest trading price 92.00%                                
Percentage of average daily trading volume 300.00%                                
Common stock value $ 250,000                                
Deferred offering cost           $ 20,000     20,000                
Dutchess [Member] | Common Stock Purchase Agreement [Member] | Restricted Stock [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Common stock value $ 20,000                                
Number of new shares issued | shares 1,000,000                                
Common stock, par value | $ / shares $ 0.02                                
Mr. Nathanielsz [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Share based compensation                 8,299                
Adjustments to additional paid in capital stock issued issuance costs                 $ 177,840                
Mr. Nathanielsz [Member] | Nathanielsz Cancellation Agreement [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Common stock value     $ 186,139                            
Percentage of bonus of annual base salary       78.00%                          
Officers compensation       $ 177,840                          
Debt Conversion Converted Instrument Shares Issued | shares     5,928,000                            
Share price | $ / shares     $ 0.03                            
Maximum [Member] | Convertible Debt [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Debt instrument contractual conversion price | $ / shares           $ 0.04     $ 0.04                
Maximum [Member] | Dutchess [Member] | Common Stock Purchase Agreement [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Stock issued during period, value $ 5,000,000                                
Minimum [Member] | Convertible Debt [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Debt instrument contractual conversion price | $ / shares           $ 0.01     $ 0.01                
Series A Preferred Stock [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Preferred stock shares authorized | shares           500,000     500,000   500,000 500,000     500,000    
Preferred stock per share value | $ / shares           $ 0.01     $ 0.01   $ 0.01            
Preferred stock shares issued | shares           500,000     500,000   500,000 500,000     500,000    
Preferred stock shares outstanding | shares           500,000     500,000   500,000 500,000     500,000    
Stock issued during period, shares | shares                 0   0            
Series B Preferred Stock [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Preferred stock shares authorized | shares           5     5   5 5     5    
Preferred stock per share value | $ / shares           $ 0.01     $ 0.01   $ 0.01            
Preferred stock shares issued | shares           1     1   1 1     1    
Preferred stock shares outstanding | shares           1     1   1 1     1    
Stock issued during period, shares | shares                 0   0            
Series B Preferred Stock [Member] | Nathanielsz [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Beneficial ownership shares | shares           1     1     1          
Series B Preferred Stock [Member] | Maximum [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Preferred stock shares authorized | shares           5     5     5          
Series B Warrant [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Exercise of warrants | shares           0 9,375   0     0          
Preferred Stock [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Preferred stock shares authorized | shares           1,500,005     1,500,005     1,500,005          
Preferred stock per share value | $ / shares           $ 0.01     $ 0.01                
Common Stock [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Stock issued during period, shares | shares     2,800,000                            
Common stock value     $ 87,920                            
Stock issued during period shares employee benefit plan | shares     2,800,000                            
Bonus payable                     $ 84,000            
Shares issued price per share | $ / shares     $ 0.03                            
Share based compensation                 $ 3,920                
Common stock shares issued | shares           2,500 6,875   2,500     2,500 2,500        
Common Stock [Member] | Legal Services [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Common stock value     $ 7,883                            
Stock issued during period shares employee benefit plan | shares     166,667                            
Shares issued price per share | $ / shares     $ 0.05                            
Share based compensation                 $ 7,883                
Common Stock [Member] | Consultant Services [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Common stock value   $ 104,611                              
Stock issued during period shares employee benefit plan | shares   2,819,712                              
Shares issued price per share | $ / shares   $ 0.04                              
Common Stock [Member] | Underlying Financing Agreements [Member] | Convertible Debt [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Common stock reserved for future issuance | shares           266,478,379     266,478,379     266,478,379          
Warrant [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Proceeds from issuance of warrants             $ 275,000                    
Stockholders equity note subscriptions receivable             $ 100,000           $ 100,000